下一代診斷全球市場展望（2023 年）

本報告研究和分析了全球下一代診斷市場，提供了每個地區的市場趨勢和增長預測以及未來增長機會等信息。

內容

戰略要務

• 為什麼越來越難成長？
• 戰略要務 8 (TM)
• 三大戰略要務對下一代診斷行業的影響
• 增長機會推動增長管道引擎 (TM)

成長環境

• 市場細分
• 成長環境

宏觀經濟因素

• 5 大全球經濟亮點（2022 年）
• 5 大全球經濟亮點（2023 年）
• 全球 GDP 增長預測
• 主要經濟體的衰退/放緩預測
• 全球 GDP 增長概況
• 發達經濟預測 (2023)
• 新興市場預測 (2023)
• 區域風險和政策方向 (2023)
• 供應鏈中斷 - 影響分析
• 經濟不確定性 - 影響分析

收入趨勢 - 2023

• 下一代診斷市場工作流程
• 收入預測：按部門分類
• IVD創新技術的影響與應用
• 競爭環境
• 收益分成
• 收益分成分析
• 競爭矩陣

併購

• 著名的併購（2022 年）
• 併購 - 歷史分析

6 大預測 - 2023

• 預測 1：人員短缺將推動 2023 年實驗室自動化實現兩位數增長
• 預測 2：25% 的綜合症組檢測增長來自傳染病部分
• 預測 3：通過監管變革增加證據生成潛力支持轉型的數字病理學集
• 預測 4：預計臨床實驗室服務將在美國和歐盟市場繼續受到整合活動
• 預測 5：腫瘤檢測在因 COVID-19 大流行而受到抑制兩年後重拾勢頭
• 預測 6：實驗室預算將保持不變。 成本壓力可能會延遲實驗室經理投資新設備

細分市場展望 - 2023

• 市場概況 (2023)

臨床化學與免疫分析 - 2023

• 臨床化學和免疫分析市場概況
• 臨床化學和免疫測定市場 - 值得關注的公司

分子診斷學 - 2023

• 分子診斷市場概況
• 分子診斷市場 - 值得關注的公司

床旁檢測 - 2023

• POCT 市場概況
• POCT 市場 - 值得關注的公司
• 收入預測：按地區
• 收入預測：按地區
• 收入預測分析 - 下一代診斷市場：按地區

成長機會

• 增長機會 1：用於精準腫瘤學的液體活檢
• 增長機會 2：人工智能在分子診斷中的整合
• 增長機會 3：互聯實驗室、智能實驗室
• 增長機會 4：傳染病的分散式 POCT
• 增長機會 5：中東和非洲的基因組學

結論

下一步

Automation and Digitization Drive the Next Growth Phase Post-COVID-19

As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on structural solutions that enhance healthcare delivery for sustainable growth. That is why automation and robotization solutions for tasks and processes are important. Besides digital solutions that allow physicians to remotely monitor and connect with patients, they should also facilitate real-time digital responses.

The study examines next-generation diagnostics market trends and growth projections to 2028 across different geographical regions, innovative in vitro diagnostics technologies and applications, major vendors to watch, and growth opportunities in the post-pandemic future.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Next-generation Diagnostics Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Environment

• Market Segmentation
• Growth Environment

Macroeconomic Factors

• Top 5 Global Economic Highlights of 2022
• Top 5 Global Economic Highlights of 2023
• Global GDP Growth Expectations
• Recessionary/Slowdown Expectations for Major Economies
• Global GDP Growth Snapshot
• Advanced Economy Predictions for 2023
• Emerging Market Economy Predictions for 2023
• 2023 Regional Risks and Policy Direction
• Supply Chain Disruptions-Impact Analysis
• Economic Uncertainties-Impact Analysis

Revenue Trends-2023

• Next-generation Diagnostics Market Workflow
• Revenue Forecast by Segment
• Revenue Forecast by Segment (continued)
• Impact and Applications of Innovative Technologies in IVD
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Competitor Matrix
• Competitor Matrix (continued)

Mergers and Acquisitions

• Notable Mergers and Acquisitions in 2022
• M&A-Historical Analytics

Top 6 Predictions-2023

• Prediction 1: Staff Shortages to Push Double-digit Laboratory Automation Growth Rate in 2023
• Prediction 2: 25% of the Total Growth in Syndromic Panel Testing to Come from the Infectious Disease Segment
• Prediction 3: Digital Pathology Set for Transformation Supported by Better Evidence-generation Possibilities Due to Regulatory Changes
• Prediction 4: Clinical Lab Services are Expected to Undergo Continuous Consolidation Activities in the US and EU Markets
• Prediction 5: Oncology Testing to Regain Traction After Being Subdued for 2 Years Owing to the COVID-19 Pandemic
• Prediction 6: Lab Budgets to Remain Flat; Lab Managers may Look to Delay Capex on New Instruments/Equipment Due to Cost Pressures

Segment Outlook-2023

• 2023 Market Snapshot

Clinical Chemistry and Immunoassays-2023

• Clinical Chemistry and Immunoassays Market Snapshot
• Clinical Chemistry and Immunoassays Market-Companies to Watch

Molecular Diagnostics-2023

• Molecular Diagnostics Market Snapshot
• Molecular Diagnostics Market-Companies to Watch

Point-of-care Testing-2023

• POCT Market Snapshot
• POCT Market-Companies to Watch
• Revenue Forecast by Region
• Percent Revenue Forecast by Region
• Revenue Forecast Analysis by Region-Next-generation Diagnostics Market

Growth Opportunity Universe

• Growth Opportunity 1: Liquid Biopsy for Precision Oncology
• Growth Opportunity 1: Liquid Biopsy for Precision Oncology (continued)
• Growth Opportunity 2: Integration of AI in Molecular Diagnostics
• Growth Opportunity 2: Integration of AI in Molecular Diagnostics (continued)
• Growth Opportunity 3: Connected and Smart Labs
• Growth Opportunity 3: Connected and Smart Labs (continued)
• Growth Opportunity 4: Decentralized POCT for Infectious Diseases
• Growth Opportunity 4: Decentralized POCT for Infectious Diseases (continued)
• Growth Opportunity 5: Genomics in the Middle East and Africa
• Growth Opportunity 5: Genomics in the Middle East (continued)

Conclusions

• Conclusions and Future Outlook
• Future of Diagnostics

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer